CLEC7A as a potential biomarker of atherosclerotic response to aspirin therapy: a multi-omics analysis
Many patients with atherosclerotic cardiovascular disease (ASCVD) do not respond well to aspirin therapy. This study employed a multi-omics approach to identify key genes associated with aspirin non-responsiveness, thereby providing potential molecular…